Condensed Consolidated Statements of Stockholders' Equity and Accumulated Other Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Balance beginning (in shares) at Dec. 31, 2020		62,545,275
Balance beginning at Dec. 31, 2020	$ 123	$ 6	$ 98,620	$ (98,887)	$ 384
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		55,762
Common stock issued upon exercise of stock options (in shares)	55		55
Stock-based compensation	627		627
Net income (loss)	(53,571)			(53,571)
Other comprehensive income (loss)	466				466
Ending balance at Mar. 31, 2021	(52,300)	$ 6	99,302	(152,458)	850
Ending balance (in shares) at Mar. 31, 2021		62,601,037
Balance beginning (in shares) at Dec. 31, 2021		141,301,569
Balance beginning at Dec. 31, 2021	303,510	$ 16	361,542	(56,797)	(1,251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		117,420
Common stock issued upon exercise of stock options (in shares)	34		34
Stock-based compensation	1,194		1,194
Net income (loss)	7,346			7,346
Other comprehensive income (loss)	(3,690)				(3,690)
Ending balance at Mar. 31, 2022	$ 308,394	$ 16	$ 362,770	$ (49,451)	$ (4,941)
Ending balance (in shares) at Mar. 31, 2022		141,418,989